Literature DB >> 1717181

Resistance of the immature hippocampus to seizure-induced synaptic reorganization.

E F Sperber1, K Z Haas, P K Stanton, S L Moshé.   

Abstract

Temporal lobe epilepsy is a common form of epilepsy in human adults and is associated with a unique pattern of damage in the hippocampus. The damage includes cell loss of the CA3 and CA4 areas and synaptic growth (sprouting) of mossy fibers in the supragranular layer of the dentate gyrus. Experimental evidence indicates that in adult rats the excitatory amino acid, kainic acid, induces a similar pattern of changes in hippocampal circuitry associated with alterations in perforant path excitation and inhibition. It has been suggested that, in humans, this type of damage may be a result of seizures early in life. In this study we examined the effects of kainic acid-induced status epilepticus on synaptic reorganization and paired-pulse electrophysiology in developing rats and adults. Kainic acid induced more severe seizures in 15-day-old rat pups than in adults. In contrast to adult rats, these seizures did not produce CA3/CA4 neuronal loss, mossy fiber sprouting or changes in paired-pulse excitation or inhibition in the hippocampus of rat pups tested 2-4 weeks after status epilepticus. Our results provide evidence that the immature hippocampus may be more resistant to seizure-induced changes than the mature hippocampus.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1717181     DOI: 10.1016/0165-3806(91)90158-f

Source DB:  PubMed          Journal:  Brain Res Dev Brain Res        ISSN: 0165-3806


  40 in total

1.  Long-term neuroplasticity and functional consequences of single versus recurrent early-life seizures.

Authors:  Tallie Z Baram
Journal:  Ann Neurol       Date:  2003-12       Impact factor: 10.422

2.  Is neuronal death necessary for acquired epileptogenesis in the immature brain?

Authors:  F Edward Dudek; Jeffrey J Ekstrand; Kevin J Staley
Journal:  Epilepsy Curr       Date:  2010-07       Impact factor: 7.500

3.  Bilateral reductions in hippocampal volume in adults with epilepsy and a history of febrile seizures.

Authors:  W B Barr; M Ashtari; N Schaul
Journal:  J Neurol Neurosurg Psychiatry       Date:  1997-10       Impact factor: 10.154

4.  Null mutation of c-fos impairs structural and functional plasticities in the kindling model of epilepsy.

Authors:  Y Watanabe; R S Johnson; L S Butler; D K Binder; B M Spiegelman; V E Papaioannou; J O McNamara
Journal:  J Neurosci       Date:  1996-06-15       Impact factor: 6.167

5.  Selective death of hippocampal CA3 pyramidal cells with mossy fiber afferents after CRH-induced status epilepticus in infant rats.

Authors:  C E Ribak; T Z Baram
Journal:  Brain Res Dev Brain Res       Date:  1996-02-26

6.  Synaptic reorganization in subiculum and CA3 after early-life status epilepticus in the kainic acid rat model.

Authors:  Devin J Cross; José E Cavazos
Journal:  Epilepsy Res       Date:  2006-10-27       Impact factor: 3.045

Review 7.  Developmental seizure models.

Authors:  L Velísek; J Velísková; S L Moshé
Journal:  Ital J Neurol Sci       Date:  1995 Feb-Mar

8.  Nicotinamide prevents the long-term effects of perinatal asphyxia on apoptosis, non-spatial working memory and anxiety in rats.

Authors:  Paola Morales; Nicola Simola; Diego Bustamante; Francisco Lisboa; Jenny Fiedler; Peter J Gebicke-Haerter; Micaela Morelli; R Andrew Tasker; Mario Herrera-Marschitz
Journal:  Exp Brain Res       Date:  2009-12-11       Impact factor: 1.972

9.  Serial MRI after experimental febrile seizures: altered T2 signal without neuronal death.

Authors:  Céline Dubé; Hon Yu; Orhan Nalcioglu; Tallie Z Baram
Journal:  Ann Neurol       Date:  2004-11       Impact factor: 10.422

10.  Transcriptome analysis of the hippocampal CA1 pyramidal cell region after kainic acid-induced status epilepticus in juvenile rats.

Authors:  Hanna B Laurén; Francisco R Lopez-Picon; Annika M Brandt; Clarissa J Rios-Rojas; Irma E Holopainen
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.